Masimo

Masimo Graham Number

Delisted

The Graham Number of Masimo (MASI) as of Oct 11, 2026 is 29.49 USD. In the previous year, Graham Number was 38.36 USD — a change of -23.14% (lower).

Graham Number

29.49USD

YoY

-23.14%

Last updated:

Graham Number of Masimo is 2023 29.49 USD. Graham Number of Masimo was 2022 38.36 USD. It decreases by -23.14% lower compared to the previous year.

The Masimo Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2016
36.13 USD
Jan 1, 2017
26.82 USD
Jan 1, 2018
37.35 USD
Jan 1, 2019
40.98 USD
Jan 1, 2020
49.38 USD
Jan 1, 2021
50.86 USD
Jan 1, 2022
38.36 USD
Jan 1, 2023
29.49 USD
The Masimo Graham Number history
YEARGraham NumberYoY
29.49USD-23.14%
38.36USD-24.56%
50.86USD+2.99%
49.38USD+20.48%
40.98USD+9.74%
37.35USD+39.23%
26.82USD-25.76%
36.13USD+167.89%
13.49USD+1.83%
13.24USD—
Access this data via the Eulerpool API

Masimo Stock analysis

What does Masimo do? Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Masimo stock

Graham Number of Masimo is 29.49 USD in 2023.

On Eulerpool you can find the complete historical development of Graham Number Masimo since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

Quality — Masimo

All Key Metrics — Masimo